Eisler Capital (Us) LLC Merck & Co., Inc. Call Options Transaction History

Eisler Capital (Us) LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$111.15 - $128.97 $1.67 Million - $1.93 Million	15,000 Added 65.5%	37,900 $4.3 Billion
Q2 2024 Aug 13, 2024	SELL	$123.8 - $132.96 $3.24 Million - $3.48 Million	-26,200 Reduced 53.36%	22,900 $2.84 Billion
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $418,988 - $488,214	3,700 Added 8.15%	49,100 $6.48 Billion
Q4 2023 Feb 13, 2024	SELL	$100.18 - $109.02 $480,864 - $523,296	-4,800 Reduced 9.56%	45,400 $4.95 Billion
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $4.22 Million - $4.69 Million	41,000 Added 445.65%	50,200 $5.17 Billion
Q2 2023 Aug 14, 2023	SELL	$108.61 - $118.38 $1.28 Million - $1.4 Million	-11,800 Reduced 56.19%	9,200 $1.06 Billion
Q1 2023 May 12, 2023	BUY	$102.94 - $114.86 $2.16 Million - $2.41 Million	21,000 New	21,000 $2.23 Billion

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Us) LLC with notifications on news.